Five SRs were included, analyzing the effects of simvastatin, antioxidants, acetyl-L-carnitine, anticonvulsants, acetylcholinesterase inhibitors (donepezil), NMDA receptor antagonists (memantine), and fast-acting intranasal insulin on dementia symptoms in DS patients. Here, INS is linked to Dravet syndrome.